Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

503 public trials 160 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Completed

A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors

NCT02999672

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +22 more
Locations: IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica Meldola, Emilia-Romagna, Italy

Irccs Ospedale San Raffaele;Oncologia Medica Milan, Lombardy, Italy

Irccs Istituto Europeo Di Oncologia (IEO); Cure Mediche Milan, Lombardy, Italy

IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima Padova, Veneto, Italy

View all 16 locations

View Trial Details

Completed

Enteral Nutrition After Pancreaticoduodenectomy

NCT03150615

Conditions: Adenocarcinoma, Ampulla of Vater Cancer, Cancer of Duodenum, +19 more
Locations: The first affiliated hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Completed

Diagnosis of Bile Duct Strictures

NCT02000999

Conditions: Adenocarcinoma, Bile Duct Stricture, Carcinoma, +19 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Completed

Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases

NCT01290536

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

NCT02053376

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +13 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma

NCT02585856

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Hangzhou First People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Completed

Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

NCT02649712

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +15 more
Locations: Xuzhou Central Hospital Xuzhou, Jiangsu, China

View Trial Details

Completed

Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma

NCT02181634

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +10 more
Locations: Colorado Cancer Research Program Denver, Colorado, United States

Northwestern University Chicago, Illinois, United States

Advocate Christ Medical Center Oak Lawn, Illinois, United States

Siouxland Hematology-Oncology Associates Sioux City, Iowa, United States

View all 25 locations

View Trial Details

Completed

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

NCT01438554

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy

NCT02609958

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Singapore

Seoul, South Korea

Taipei, Taiwan

View Trial Details

Cholangiocarcinoma

Cholangiocarcinoma trial results

Related conditions